Acceleron Pharma
XLRN
#1901
Rank
NZ$18.52 B
Marketcap
NZ$302.95
Share price
0.00%
Change (1 day)
15,181.03%
Change (1 year)

Market capitalization of Acceleron Pharma (XLRN)

Last known market cap: NZ$18.52 Billion

As of May 2026 Acceleron Pharma has a market cap of NZ$18.52 Billion. This makes Acceleron Pharma the world's 1901th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Acceleron Pharma from 2013 to 2022

End of year Market Cap

Year Marketcap Change
2022NZ$17.21 B7.58%
2021NZ$16.00 B49.8%
2020NZ$10.68 B155.45%
2019NZ$4.18 B39.24%
2018NZ$3.00 B11.11%
2017NZ$2.70 B94.38%
2016NZ$1.39 B-41.41%
2015NZ$2.37 B47.17%
2014NZ$1.61 B18.05%
2013NZ$1.36 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
NZ$926.87 B 4,902.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$253.83 B 1,270.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$301.67 B 1,528.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$124.62 B 572.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
NZ$94.78 M-99.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
NZ$35.42 M-99.81%๐Ÿ‡บ๐Ÿ‡ธ USA
bluebird bio
BLUE
NZ$82.48 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA